UK's BHF (British Heart Foundation) urges proper screening for OTC (over-the-counter) statin patients
This article was originally published in Clinica
Executive Summary
News as Clinica went to press that Merck's cholesterol-lowering drug, Zocor (simvastatin), is to be made available OTC in the UK has been given a guarded welcome by the British Heart Foundation, amid concerns that public access needs to be supported by appropriate testing and monitoring. Pending confirmation of how this might be ensured, the BHF called for "patients to be encouraged to accept the offer of reliable cholesterol checks", telling Clinica that testing measures would be an important element of the initiative.
You may also be interested in...
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.